Acurx Pharmaceuticals Q2 EPS $(0.53) Misses $(0.37) Estimate

Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.37) by 43.24 percent. This is a 71.96 percent increase over losses of $(1.89) per share from the same period last year.